









市場
/
株式
/
nasdaq-slp
/

Simulations Plus Inc

SLP

13.005USD

+0.205+1.60%

取引時間（ET）15分遅れの株価

261.61M時価総額

36.03直近12ヶ月PER



Simulations Plus Inc

13.005

+0.205+1.60%

概要企業名金融

Simulations Plus, Inc. is a provider in the biopharma sector, offering advanced software and consulting services that enhance drug discovery, development, research, clinical trial operations, regulatory submissions, and commercialization. It operates through two segments: software and services. The Company’s business units include cheminformatics, physiologically based pharmacokinetics, clinical pharmacology and pharmacometrics, quantitative systems pharmacology, adaptive learning & insights and medical communications. The Company operates in biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry. It delivers simulation-enabled performance and intelligence solutions alongside medical communications support for clinical and commercial drug development. Its cutting-edge technology is licensed and utilized by pharmaceutical, biotechnology, and regulatory agencies worldwide.

企業情報

企業コードSLP

会社名Simulations Plus Inc

上場日Jun 18, 1997

最高経営責任者「CEO」Mr. Shawn M. O'Connor

従業員数243

証券種類Ordinary Share

決算期末Jun 18

本社所在地800 Park Offices Drive, Suite 401

都市RESEARCH TRIANGLE PARK

証券取引所NASDAQ Global Select Consolidated

国United States of America

郵便番号27709

電話番号16617237723

ウェブサイトhttps://www.simulations-plus.com/

企業コードSLP

上場日Jun 18, 1997

最高経営責任者「CEO」Mr. Shawn M. O'Connor

役員一覧

会社名

会社名/ポジション

ポジション

株式保有

変動額

Dr. Hon. Walter S. Woltosz

Independent Director

3.30M

-0.60%

Ms. Jill Fiedler-Kelly

Interim President - Services Solutions

68.87K

Ms. Sharlene Evans

Independent Director

9.44K

+9.09%

Dr. John Kenneth Paglia, Ph.D.

Independent Director

6.85K

+12.96%

Mr. Erik Guffrey

Co-Chief Product and Technology Officer

Mr. Josh Fohey

Chief Operating Officer

Mr. Shawn M. O'Connor

Chief Executive Officer

Mr. Steven Chang

Global Head - Strategic Alliances

Mr. John A. Dibella

Chief Revenue Officer

Ms. Jenna Rouse

Global Head - Clinical Operations

詳細を見る

会社名

会社名/ポジション

ポジション

株式保有

変動額

Dr. Hon. Walter S. Woltosz

Independent Director

3.30M

-0.60%

Ms. Jill Fiedler-Kelly

Interim President - Services Solutions

68.87K

Ms. Sharlene Evans

Independent Director

9.44K

+9.09%

Dr. John Kenneth Paglia, Ph.D.

Independent Director

6.85K

+12.96%

Mr. Erik Guffrey

Co-Chief Product and Technology Officer

Mr. Josh Fohey

Chief Operating Officer

収益内訳

通貨: USD更新時刻: Sun, Jul 6

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2021

FY2020

FY2019

事業別USD

会社名

収益

比率

Software licenses

13.48M

60.11%

Consulting services

8.95M

39.89%

地域別USD

会社名

収益

比率

Americas

16.11M

71.83%

Europe

4.81M

21.42%

Asia

1.51M

6.75%

事業別

地域別

事業別USD

会社名

収益

比率

Software licenses

13.48M

60.11%

Consulting services

8.95M

39.89%

株主

更新時刻: Fri, Aug 1

株主統計

種類

株主統計

比率

Woltosz (Walter S)

16.42%

BlackRock Institutional Trust Company, N.A.

11.37%

Conestoga Capital Advisors, LLC

6.37%

The Vanguard Group, Inc.

5.44%

Janus Henderson Investors

4.45%

Other

55.95%

株主統計

比率

Woltosz (Walter S)

16.42%

BlackRock Institutional Trust Company, N.A.

11.37%

Conestoga Capital Advisors, LLC

6.37%

The Vanguard Group, Inc.

5.44%

Janus Henderson Investors

4.45%

Other

55.95%

種類

株主統計

比率

Investment Advisor

40.20%

Investment Advisor/Hedge Fund

36.04%

Individual Investor

17.33%

Research Firm

3.35%

Hedge Fund

3.34%

Pension Fund

1.97%

Bank and Trust

1.43%

Venture Capital

0.07%

Family Office

0.04%

機関投資家保有株

更新時刻: Tue, Jul 1

報告期間

機関投資家数

保有株式数

比率

変動額

2025Q2

395

19.83M

98.53%

-2.60M

2025Q1

405

20.80M

103.44%

-1.07M

2024Q4

395

19.75M

98.32%

-353.54K

2024Q3

400

19.32M

96.55%

-155.06K

2024Q2

401

20.11M

100.50%

-787.76K

2024Q1

398

20.05M

100.34%

-310.16K

2023Q4

390

19.56M

97.97%

-570.84K

2023Q3

390

19.23M

96.46%

-1.16M

2023Q2

406

19.53M

98.02%

-1.10M

2023Q1

421

19.42M

97.11%

-1.40M

詳細を見る

株主動向

会社名

保有株式数

比率

変動額

変動率

日付

Woltosz (Walter S)

3.32M

16.53%

-20.00K

-0.60%

Jun 02, 2025

BlackRock Institutional Trust Company, N.A.

2.29M

11.38%

-24.85K

-1.07%

Mar 31, 2025

Conestoga Capital Advisors, LLC

2.61M

12.97%

+383.13K

+17.21%

Mar 31, 2025

The Vanguard Group, Inc.

1.10M

5.45%

-47.76K

-4.18%

Mar 31, 2025

Janus Henderson Investors

896.34K

4.46%

+353.44K

+65.10%

Mar 31, 2025

State Street Global Advisors (US)

706.51K

3.51%

-14.51K

-2.01%

Mar 31, 2025

Ranger Investment Management, L.P.

695.00K

3.46%

-7.30K

-1.04%

Mar 31, 2025

Dimensional Fund Advisors, L.P.

475.53K

2.36%

+56.29K

+13.43%

Mar 31, 2025

Kennedy Capital Management LLC

469.30K

2.33%

+180.01K

+62.23%

Mar 31, 2025

Columbia Threadneedle Investments (UK)

422.80K

2.1%

+28.38K

+7.20%

Mar 31, 2025

詳細を見る

関連ETF

更新時刻: Sat, Aug 2

銘柄名

比率

SPDR FactSet Innovative Technology ETF

0.57%

First Trust Active Factor Small Cap ETF

0.31%

Global X HealthTech ETF

0.3%

Invesco Nasdaq Free Cash Flow Achievers ETF

0.3%

Franklin Exponential Data ETF

0.28%

WisdomTree Artificial Intelligence and Innov Fund

0.22%

Invesco S&P SmallCap Health Care ETF

0.2%

First Trust Multi-Manager Small Cap Opportunities ETF

0.13%

JPMorgan Diversified Return U.S. Small Cap Equity ETF

0.1%

WisdomTree US SmallCap Quality Growth Fund

0.1%

詳細を見る

SPDR FactSet Innovative Technology ETF

比率0.57%

First Trust Active Factor Small Cap ETF

比率0.31%

Global X HealthTech ETF

比率0.3%

Invesco Nasdaq Free Cash Flow Achievers ETF

比率0.3%

Franklin Exponential Data ETF

比率0.28%

WisdomTree Artificial Intelligence and Innov Fund

比率0.22%

Invesco S&P SmallCap Health Care ETF

比率0.2%

First Trust Multi-Manager Small Cap Opportunities ETF

比率0.13%

JPMorgan Diversified Return U.S. Small Cap Equity ETF

比率0.1%

WisdomTree US SmallCap Quality Growth Fund

比率0.1%

配当金

過去5年間の配当金総支払額は 23.51M 米ドルである。

日付

配当金

権利確定日

支払日

配当落ち日

Jul 02, 2024

SLP.NB Interim Cash Dividend of gross USD 0.06 paid on Aug 05, 2024 going ex on Jul 29, 2024

Jul 29, 2024

Aug 05, 2024

Jul 29, 2024

Apr 03, 2024

SLP.NB Interim Cash Dividend of gross USD 0.06 paid on May 06, 2024 going ex on Apr 26, 2024

Apr 29, 2024

May 06, 2024

Apr 26, 2024

Jan 03, 2024

SLP.NB Interim Cash Dividend of gross USD 0.06 paid on Feb 05, 2024 going ex on Jan 26, 2024

Jan 29, 2024

Feb 05, 2024

Jan 26, 2024

Oct 25, 2023

SLP.NB Final Cash Dividend of gross USD 0.06 paid on Nov 06, 2023 going ex on Oct 27, 2023

Oct 30, 2023

Nov 06, 2023

Oct 27, 2023

Jul 06, 2023

SLP.NB Interim Cash Dividend of gross USD 0.06 paid on Aug 07, 2023 going ex on Jul 28, 2023

Jul 31, 2023

Aug 07, 2023

Jul 28, 2023

Apr 06, 2023

SLP.NB Interim Cash Dividend of gross USD 0.06 paid on May 01, 2023 going ex on Apr 21, 2023

Apr 24, 2023

May 01, 2023

Apr 21, 2023

Jan 05, 2023

SLP.NB Interim Cash Dividend of gross USD 0.06 paid on Feb 06, 2023 going ex on Jan 27, 2023

Jan 30, 2023

Feb 06, 2023

Jan 27, 2023

Oct 20, 2022

SLP.NB Final Cash Dividend of gross USD 0.06 paid on Nov 07, 2022 going ex on Oct 28, 2022

Oct 31, 2022

Nov 07, 2022

Oct 28, 2022

Jul 07, 2022

SLP.NB Interim Cash Dividend of gross USD 0.06 paid on Aug 01, 2022 going ex on Jul 22, 2022

Jul 25, 2022

Aug 01, 2022

Jul 22, 2022

Apr 06, 2022

SLP.NB Interim Cash Dividend of gross USD 0.06 paid on May 02, 2022 going ex on Apr 22, 2022

Apr 25, 2022

May 02, 2022

Apr 22, 2022

詳細を見る

株式分割

日付

種類

比率

データなし

日付

種類

比率

データなし

KeyAI

